Literature DB >> 16389102

Drug-eluting coronary stents.

Amar M Salam1, Jassim Al Suwaidi, David R Holmes.   

Abstract

The introduction and widespread use of coronary stents have been the most important advancement in the percutaneous treatment of coronary artery disease since the introduction of balloon angioplasty. Coronary artery stents reduce the rate of angiographic and clinical restenosis compared to balloon angioplasty. This angiographic restenosis was further reduced with the introduction of drug-eluting stents and hence further reduction in the frequency of major adverse cardiac events. Herein we present a comprehensive and up-to-date review about the use of drug-eluting stents in the treatment of coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16389102     DOI: 10.1016/j.cpcardiol.2005.09.002

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN: 0146-2806            Impact factor:   5.200


  4 in total

1.  Drug deposition in coronary arteries with overlapping drug-eluting stents.

Authors:  Farhad Rikhtegar; Elazer R Edelman; Ufuk Olgac; Dimos Poulikakos; Vartan Kurtcuoglu
Journal:  J Control Release       Date:  2016-07-16       Impact factor: 9.776

2.  Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes.

Authors:  Barry Reicher; Robert S Poston; Mandeep R Mehra; Ashish Joshi; Patrick Odonkor; Zachary Kon; Peter A Reyes; David A Zimrin
Journal:  Am Heart J       Date:  2008-03-05       Impact factor: 4.749

Review 3.  Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: systematic review and meta-analysis.

Authors:  Peng Zhu; Pengyu Zhou; Yong Sun; Yilong Guo; Mingjie Mai; Shaoyi Zheng
Journal:  J Cardiothorac Surg       Date:  2015-05-01       Impact factor: 1.637

4.  Immediate results and six-month clinical outcome after percutaneous coronary intervention in patients with prior coronary artery bypass surgery.

Authors:  Fatemeh Behboudi; Hossein Vakili; Seyed Reza Hashemi; Manouchehr Hekmat; Morteza Safi; Mohammad Hasan Namazi
Journal:  J Tehran Heart Cent       Date:  2011-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.